BASF to build formic acid plant in US
BASF has announced plans for a new formic acid production plant in the US, citing the pharmaceutical industry among its key customer targets.
Archives for May 6, 2012
EXCLUSIVE
Single-use is the future of biomanufacturing: report from Interphex
Advancements in single-use equipment are crucial to the development of the biotechnology industry, according to experts at this year’s Interphex.
SGS adds formulation development services and expands US lab
SGS has added formulation development to its service offering through the expansion of its laboratory in Illinois.
EMA outlines manufacturing quality docs for biologics trials
The EMA has published final guidelines on manufacturing quality documents needed for biologics entering clinical trials.
Generics rise sparks delivery tech need; Interphex speaker
The need for novel delivery technologies is greater than ever as firms scramble to extract maximum value from drugs, an Interphex speaker said.
Marken buys sampling kit unit and bags LabCorp as a customer
Marken has bought the European kit building unit of LabCorp’s clinical trials division in a continuation of its efforts to grow into a full service contract logistics supplier.
Charles River CEO downplays interest in asset transfer deals
The CEO of Charles River said asset transfer strategic deals make little “rational sense” to clients or CROs.